May 1, 2018 | News Coverage
How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma Another pharmaceutical giant’s rising insulin prices, means bad news for consumers. In this article from Fortune and Kasier Health News, the journalists shed light on how lobbying impacts the...
Apr 18, 2018 | News Coverage
news An Unlikely Treatment for a Rare Disease Journalist Sarah Jane Tribble wrote a fascinating piece for the Washington Post that uses Connecture drug data and spotlights the Orphan Drug Korlym. This drug has a controversial origin as “the abortion pill,” but is also...
Apr 6, 2018 | News Coverage
news These New Pharma Bros Are Wreaking Havoc on Prescription Drug Prices Fascinating Bloomberg story that leverages Connecture’s data and highlights a Chicago-based duo that’s selling a simple Rx strategy — and companies they’ve worked with have raised prices on...
Mar 22, 2018 | News Coverage
news 3 Critical Lessons for FMOs in the Medicare World Earlier this month, Connecture hosted its first-ever FMO Council Meeting in its Chicago Innovation Hub. Connecture SVP and broker expert Joe Donlan writes about that experience and his three biggest takeaways from...
Mar 6, 2018 | News Coverage
news Pharmaceutical Titan’s Senate Bid Will Test Voters’ Views on Drug Prices In her latest article, Bloomberg’s Rebecca Spalding discusses the role drug prices are playing in American politics. Connecture prescription drug data is featured. Read the full article...
Feb 12, 2018 | News Coverage
news The Bright Future of Non-Traditional Benefits Health insurance is always making headlines these days, particularly as Washington continues to debate over the ACA. But what about the non-traditional benefits that don’t get nearly as much coverage? Our own Amy...
